Biosimilars in Oncology: Latest Trends and Regulatory Status

• প্রধান লেখক: Deeksha Joshi (লেখক), Rubiya Khursheed (লেখক), Saurabh Gupta (লেখক), Diksha Wadhwa (লেখক), Thakur Gurjeet Singh (লেখক), Sumit Sharma (লেখক), Sejal Porwal (লেখক), Swati Gauniyal (লেখক), Sukriti Vishwas (লেখক), Sanjay Goyal (লেখক), Gaurav Gupta (লেখক), Rajaraman D. Eri (লেখক), Kylie A. Williams (লেখক), Kamal Dua (লেখক), Sachin Kumar Singh (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2022-12-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Biologic-based medicines are used to treat a variety of diseases and account for around one-quarter of the worldwide pharmaceutical market. The use of biologic medications among cancer patients has resulted in substantial advancements in cancer treatment and supportive care. Biosimilar medications (...